EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Association of Circulating PCSK9 With Ischemia-Reperfusion Injury in Acute ST-Elevation Myocardial Infarction

Christina Tiller iD, Magdalena Holzknecht iD, Ivan Lechner iD, Fritz Oberhollenzer iD, Sebastian von der Emde, Thomas Kremser, Can Gollmann-Tepeköylü iD, Agnes Mayr iD, Axel Bauer iD, Bernhard Metzler iD, Sebastian J Reinstadler iD, Martin Reindl iD

Circulation: Cardiovascular Imaging · 2024

DOI: 10.1161/circimaging.123.016482 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Circulation: Cardiovascular Imaging, 2024. Verfasst von Christina Tiller und 11 weiteren Autor:innen. Beteiligte Einrichtung: University Clinic of Internal Medicine III, Cardiology and Angiology (C.T., M.H., I.L., F.O., S.E., T.K., A.B., B.M., S.J.R., M.R.), Medical Universi…. Hauptthemen laut MEDLINE: Biomarkers, Myocardial Reperfusion Injury, Percutaneous Coronary Intervention, Proprotein Convertase 9. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Austrian Society of Cardiology, Tiroler Wissenschaftsfonds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Beyond therapeutic implications, PCSK9 (proprotein convertase subtilisin/kexin 9) has emerged as a promising cardiovascular biomarker. The exact role of PCSK9 in the setting of acute ST-elevation myocardial infarction (STEMI) is incompletely understood. We aimed to investigate the association of PCSK9 with ischemia-reperfusion injury, visualized by cardiac magnetic resonance imaging, in patients with STEMI revascularized by primary percutaneous coronary intervention (PCI). METHODS: In this prespecified substudy from the prospective MARINA-STEMI (NCT04113356) registry, we included 205 patients with STEMI. PCSK9 concentrations were measured from venous blood samples by an immunoassay 24 and 48 hours after PCI. The primary end point was defined as presence of intramyocardial hemorrhage according to cardiac magnetic resonance T2* mapping. Secondary imaging end points were the presence of microvascular obstruction (MVO) and infarct size. The clinical end point was the occurrence of major adverse cardiac events. RESULTS: We observed a significant increase in PCSK9 levels from 24 to 48 hours (268–304 ng/mL; P 0.05). PCSK9 concentrations 48 hours post-STEMI were higher in patients with intramyocardial hemorrhage (333 versus 287 ng/mL; P =0.004), MVO (320 versus 292 ng/mL; P =0.020), and large infarct size (323 versus 296 ng/mL; P =0.013). Furthermore, patients with increased PCSK9 levels >361 ng/mL at 48 hours were more likely to experience major adverse cardiac events (15% versus 8%; P =0.002) during a median follow-up of 12 months. CONCLUSIONS: In patients with STEMI, a significant increase in PCSK9 was observed from 24 to 48 hours after PCI. While PCSK9 levels after 24 hours were not related to myocardial or microvascular injury, PCSK9 after 48 hours was significantly associated with intramyocardial hemorrhage, MVO, and infarct size as well as worse subsequent clinical outcomes. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier; NCT04113356.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersMyocardial Reperfusion InjuryPercutaneous Coronary InterventionProprotein Convertase 9RegistriesST Elevation Myocardial InfarctionAgedFemaleHumansMaleMiddle AgedMagnetic Resonance Imaging, CineProspective StudiesTime FactorsTreatment Outcome

Stichwörter der Autor:innen

animallipid metabolismrisk factorsserine proteasesubtilisin

Substanzen

BiomarkersPCSK9 protein, humanProprotein Convertase 9

Autor:innen und Institutionen

  • University Clinic of Internal Medicine III, Cardiology and Angiology (C.T., M.H., I.L., F.O., S.E., T.K., A.B., B.M., S.J.R., M.R.), Medical University of Innsbruck, Austria.
  • University Clinic of Cardiac Surgery (C.G.-T.), Medical University of Innsbruck, Austria.
  • University Clinic of Radiology (A.M.), Medical University of Innsbruck, Austria.

ORCID-Profile: Christina Tiller, Magdalena Holzknecht, Ivan Lechner, Fritz Oberhollenzer, Can Gollmann-Tepeköylü, Agnes Mayr, Axel Bauer, Bernhard Metzler, Sebastian J Reinstadler, Martin Reindl

Förderung

  • Austrian Society of Cardiology
  • Tiroler Wissenschaftsfonds

Zitieren

APA

Tiller, C., Holzknecht, M., Lechner, I., Oberhollenzer, F., von der Emde, S., Kremser, T., Gollmann-Tepeköylü, C., Mayr, A., Bauer, A., Metzler, B., Reinstadler, S. J., & Reindl, M. (2024). Association of Circulating PCSK9 With Ischemia-Reperfusion Injury in Acute ST-Elevation Myocardial Infarction. Circulation: Cardiovascular Imaging. https://doi.org/10.1161/circimaging.123.016482

Vancouver

Tiller C, Holzknecht M, Lechner I, Oberhollenzer F, von der Emde S, Kremser T, et al. Association of Circulating PCSK9 With Ischemia-Reperfusion Injury in Acute ST-Elevation Myocardial Infarction. Circulation: Cardiovascular Imaging. 2024. doi:10.1161/circimaging.123.016482

BibTeX
@article{Tiller2024,
  author = {Tiller, Christina and Holzknecht, Magdalena and Lechner, Ivan and Oberhollenzer, Fritz and von der Emde, Sebastian and Kremser, Thomas and Gollmann-Tepeköylü, Can and Mayr, Agnes and Bauer, Axel and Metzler, Bernhard and Reinstadler, Sebastian J and Reindl, Martin},
  title = {Association of Circulating PCSK9 With Ischemia-Reperfusion Injury in Acute ST-Elevation Myocardial Infarction},
  journal = {Circulation: Cardiovascular Imaging},
  year = {2024},
  doi = {10.1161/circimaging.123.016482}
}
Kostenlos starten →